title: The HEDIS Medication Management for People with Asthma Measure is Not Related to Improved Asthma Outcomes.
abstract: BACKGROUND
  A new Healthcare Effectiveness Data and Information Set (HEDIS) asthma quality-of-care measure designed to quantify patient adherence to asthma controller medication has been implemented. The relationship between this measure and asthma outcomes is unknown.
  
  
  OBJECTIVE
  To examine the relationship between the HEDIS Medication Management for people with Asthma (MMA) measure and asthma outcomes.
  
  
  METHODS
  Administrative data identified 30,040 patients who met HEDIS criteria for persistent asthma during 2012. These patients were classified as compliant or noncompliant with the MMA measure at the 75% and 50% threshold, respectively. The association between MMA compliance in 2012 and asthma outcomes in 2013 was determined.
  
  
  RESULTS
  Patients who were 75% or 50% MMA compliant in 2012 showed no clinically meaningful difference in asthma-related hospitalizations, emergency department visits, or rescue inhaler dispensing in 2013 compared with those who were noncompliant. Stepwise comparison of patients who were 75% or more, 50% to 74%, and less than 50% MMA compliant showed no meaningful difference in asthma outcomes between groups.
  
  
  CONCLUSIONS
  Compliance with the HEDIS MMA measure is not related to improvement in the asthma outcomes assessed (rescue inhaler dispensing, asthma-coded hospitalizations, or asthma-coded emergency department visits).
authors.affiliation: Department of Allergy/Clinical Immunology, Kaiser Permanente Medical Center, Los Angeles, Calif. Electronic address: angelina.crans-yoon@kp.org.
authors.forename: Angelina
authors.initials: A
authors.lastname: Crans Yoon
authors.affiliation: Department of Allergy, Kaiser Permanente Medical Center, Gardena, Calif.
authors.forename: William
authors.initials: W
authors.lastname: Crawford
authors.affiliation: Department of Allergy/Clinical Immunology, Kaiser Permanente Medical Center, Los Angeles, Calif.
authors.forename: Javed
authors.initials: J
authors.lastname: Sheikh
authors.affiliation: Department of Allergy, Kaiser Permanente Medical Center, San Diego, Calif.
authors.forename: Randy
authors.initials: R
authors.lastname: Nakahiro
authors.affiliation: Department of Research and Evaluation, Kaiser Permanente, Pasadena, Calif.
authors.forename: Aili
authors.initials: A
authors.lastname: Gong
authors.affiliation: Department of Allergy, Kaiser Permanente Medical Center, San Diego, Calif.
authors.forename: Michael
authors.initials: M
authors.lastname: Schatz
mesh_terms: D058666:Adrenergic beta-2 Receptor Agonists / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D010349:Patient Compliance; D011787:Quality of Health Care; D016896:Treatment Outcome
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D018927:Anti-Asthmatic Agents
keywords: Asthma; HEDIS; Quality measures